Details of the Drug Formulaction

General Information of Drug Formulation (ID: F16013)

Formulation Name

Ondansetron 8 mg tablet

Company

West-Ward Pharmaceticals

Pharmaceutical Drug(s) in Formulation

Drug Name	Drug ID	Indication	ICD 11	Status
Ondansetron	DMOTQ1I	Chemotherapy-induced nausea	MD90	Approved
--------------------

Pharmaceutical Excipient(s) in Formulation

Excipient Name	Excipient ID	PubChem CID	Functional Classification
Beta-D-lactose	E00099	6134	Diluent; Dry powder inhaler carrier; Lyophilization aid
Magnesium stearate	E00208	11177	lubricant

--------------------